{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:27:28Z","timestamp":1770478048644,"version":"3.49.0"},"reference-count":20,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2003,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>We have compared the in vitro activity of the new antifungal drug eberconazole with those of three other topical antifungal agents, clotrimazole, ketoconazole, and miconazole, against 200 strains of dermatophytes. MICs were determined by a microdilution method with optimal conditions determined in a previous study (an inoculum of 10<jats:sup>4<\/jats:sup>CFU\/ml, an incubation temperature of 28\u00b0C, an incubation period of 7 days, and a MIC endpoint of 100% inhibition of growth). In general, the four drugs tested showed low MICs. However, eberconazole was more active (<jats:italic>P<\/jats:italic>&lt; 0.05) than the other three drugs against the majority of the species tested. Eberconazole represents an advantageous alternative for dermatophytoses where a topical therapy is required.<\/jats:p>","DOI":"10.1128\/jcm.41.11.5209-5211.2003","type":"journal-article","created":{"date-parts":[[2003,11,6]],"date-time":"2003-11-06T19:21:05Z","timestamp":1068146465000},"page":"5209-5211","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":30,"title":["In Vitro Activities of the New Antifungal Drug Eberconazole and Three Other Topical Agents against 200 Strains of Dermatophytes"],"prefix":"10.1128","volume":"41","author":[{"given":"Belkys","family":"Ferna\u0301ndez-Torres","sequence":"first","affiliation":[{"name":"Unitat de Microbiologia, Facultat de Medicina i Cie\u0300ncies de la Salut, Universitat Rovira i Virgili, 43201 Reus, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Inza","sequence":"additional","affiliation":[{"name":"Unitat de Microbiologia, Facultat de Medicina i Cie\u0300ncies de la Salut, Universitat Rovira i Virgili, 43201 Reus, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Guarro","sequence":"additional","affiliation":[{"name":"Unitat de Microbiologia, Facultat de Medicina i Cie\u0300ncies de la Salut, Universitat Rovira i Virgili, 43201 Reus, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1439-0507.1992.tb00837.x","volume":"35","year":"1992","unstructured":"Albanese, G., R. Di Cintio, P. Giorgetti, G. Galviati, and M. Ciampini. 1992. Recurrent tinea pedis: a double blind study on the prophylactic use of fenticonazole powder. Mycoses35:157-159.","journal-title":"Mycoses"},{"key":"e_1_3_1_3_2","first-page":"340","volume":"14","year":"2001","unstructured":"Alou Cervera, L., J. R. Maestre, R. Moreno, and Grupo para el estudio del consumo de antimicrobianos en Espa\u00f1a. 2001. Consumo de antif\u00fangicos de uso t\u00f3pico en Espa\u00f1a. Rev. Esp. Quimioter.14:340-344.","journal-title":"Rev. Esp. Quimioter."},{"key":"e_1_3_1_4_2","first-page":"107","volume":"10","year":"2000","unstructured":"Bonifaz, A., and A. Saul. 2000. Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis. Eur. J. Dermatol.10:107-109.","journal-title":"Eur. J. Dermatol."},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0507.2001.00632.x"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0507.1995.tb00415.x"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.9.2524-2528.2001"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.11.3999-4003.2002"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-001-0661-5"},{"key":"e_1_3_1_10_2","first-page":"16","volume":"12","year":"1995","unstructured":"Font, E., J. Freixes, and J. Julve. 1995. Perfil del nuevo antimic\u00f3tico t\u00f3pico eberconazol. Rev. Iberoam. Micol.12:16-17.","journal-title":"Rev. Iberoam. Micol."},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000246174"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1993.tb02844.x"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199958010-00018"},{"key":"e_1_3_1_14_2","first-page":"155","volume":"10","year":"2000","unstructured":"Niewerth, M., and H. C. Korting. 2000. The use of systemic antimycotics in dermatotherapy. Eur. J. Dermatol.10:155-160.","journal-title":"Eur. J. Dermatol."},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.7.2618-2621.2002"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200203020-00001"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0507.1999.00477.x"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0507.2002.00724.x"},{"key":"e_1_3_1_19_2","first-page":"43","volume":"16","year":"1999","unstructured":"Torres-Rodr\u00edguez, J. M., N. Madrenys-Brunet, and L. Montsant. 1999. Tratamiento t\u00f3pico de la candidosis cut\u00e1nea experimental del cobayo con eberconazol. Rev. Iberoam. Micol.16:43-45.","journal-title":"Rev. Iberoam. Micol."},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.5.1258"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3062.1999.010404.x"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.41.11.5209-5211.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.41.11.5209-5211.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T08:32:08Z","timestamp":1704961928000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.41.11.5209-5211.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["10.1128\/JCM.41.11.5209-5211.2003"],"URL":"https:\/\/doi.org\/10.1128\/jcm.41.11.5209-5211.2003","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,11]]},"assertion":[{"value":"2003-05-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-08-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-11-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}